Skip to search.
 FTSE 100 Up 0.26%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
295.00 Down 2.00(0.67%) 22 May 16:39
Add to Portfolio
Prev Close:297.00
Open:296.50
Bid:290.75
Ask:291.25
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:289.25 - 296.50
52wk Range:229.50 - 379.19
Volume:33,183
Avg Vol (3m):183,398
Market Cap:308.93m
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.15
P/S (ttm):421.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :17.97
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops and sells oral and inhalation pharmaceutical products. The company’s inhalation products include flutiform, a multi-dose pressurized metered dose inhaler for the treatment of bronchial asthma; Anoro Ellipta and Incruse... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback